Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Myricx Pharma secured £4.5M from life sciences investors Sofinnova Partners and Brandon Capital Partners

Myricx Pharma secured £4.5M from life sciences investors Sofinnova Partners and Brandon Capital Partners

Health services Pharma

United Kingdom

Australia

France

Investments

17 November 2020

Share:

Myricx Bio (company)

United Kingdom

Health services Pharma

Total investments received (USD): 120.02m

Round value (USD): 6.02m

Round investors: Brandon Capital Partners Sofinnova Partners

Company: Myricx Bio

Industry: Health services Pharma

Related deals

Theolytics to raise £5 million Series A round led by co-led by Epidarex Capital and Taiho Ventures LLC

Biotech Health services Pharma

United Kingdom

United States

Japan

Investments 06 January 2021

MIP Diagnostics secured £5.1M funding from Mercia Asset Management

Biotech Health services Manufacturing Pharma Software Services

United Kingdom

Investments 07 July 2020

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top